SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-363150
Filing Date
2021-12-21
Accepted
2021-12-21 09:16:01
Documents
14
Period of Report
2021-12-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d275731d8k.htm   iXBRL 8-K 25334
2 EX-99.1 d275731dex991.htm EX-99.1 7942
6 GRAPHIC g275731dsp03.jpg GRAPHIC 15026
  Complete submission text file 0001193125-21-363150.txt   180469

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcab-20211216.xsd EX-101.SCH 2889
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcab-20211216_lab.xml EX-101.LAB 18123
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcab-20211216_pre.xml EX-101.PRE 11403
8 EXTRACTED XBRL INSTANCE DOCUMENT d275731d8k_htm.xml XML 3342
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39787 | Film No.: 211507004
SIC: 2836 Biological Products, (No Diagnostic Substances)